id	sid	eid	entity	type
dti-1423	1	1	1drug	CARDINAL
dti-1423	1	2	junichi kitanaka1	PERSON
dti-1423	1	3	kitanaka1	PERSON
dti-1423	1	4	f. scott hall2	PERSON
dti-1423	1	5	george r. uhl3	PERSON
dti-1423	1	6	takemura1	PERSON
dti-1423	2	1	japan	GPE
dti-1423	3	1	2department	TIME
dti-1423	3	2	university of toledo	ORG
dti-1423	3	3	toledo	GPE
dti-1423	4	1	3new	CARDINAL
dti-1423	4	2	mexico va	LOC
dti-1423	4	3	albuquerque	GPE
dti-1423	4	4	usa.	GPE
dti-1423	8	1	metoprine	ORG
dti-1423	8	2	one	CARDINAL
dti-1423	10	1	metoprine	ORG
dti-1423	10	2	kitanaka et al	PERSON
dti-1423	11	1	2016:10 1–7 doi:10.4137/dti.s38342	MONEY
dti-1423	12	1	december 23, 2015	DATE
dti-1423	13	1	january 25, 2016	DATE
dti-1423	14	1	january 27, 2016	DATE
dti-1423	15	1	anuj chauhan	PERSON
dti-1423	15	2	four	CARDINAL
dti-1423	16	1	341	CARDINAL
dti-1423	17	1	nk	ORG
dti-1423	17	2	jsps kakenhi	PERSON
dti-1423	17	3	15k08603	CARDINAL
dti-1423	19	1	metoprine	ORG
dti-1423	19	2	glaxosmithkline	PERSON
dti-1423	22	1	3.0	CARDINAL
dti-1423	23	1	kitanaka-hyg@umin.net	ORG
dti-1423	26	1	third	ORDINAL
dti-1423	31	1	2016	CARDINAL
dti-1423	31	2	10	CARDINAL
dti-1423	31	3	kitanaka et al	PERSON
dti-1423	31	4	amph	ORG
dti-1423	31	5	1	CARDINAL
dti-1423	33	1	japan	GPE
dti-1423	39	1	http://www.la-press.com/drug-target-insights-journal-j23	CARDINAL
dti-1423	39	2	al 2	ORG
dti-1423	39	3	0.5–2	CARDINAL
dti-1423	40	1	follows35	PERSON
dti-1423	40	2	30	CARDINAL
dti-1423	40	3	30	CARDINAL
dti-1423	40	4	35 cm	QUANTITY
dti-1423	40	5	~25	ORG
dti-1423	40	6	one hour	TIME
dti-1423	41	1	minutes	TIME
dti-1423	41	2	10	CARDINAL
dti-1423	41	3	kg i.p.	PERSON
dti-1423	41	4	two-hour	TIME
dti-1423	41	5	one hour	TIME
dti-1423	41	6	two-hour observations38	TIME
dti-1423	41	7	one-hour	TIME
dti-1423	42	1	one hour	TIME
dti-1423	43	1	30-second	TIME
dti-1423	44	1	seconds	TIME
dti-1423	46	1	four	CARDINAL
dti-1423	48	1	1 mg/kg	QUANTITY
dti-1423	48	2	five-minute	TIME
dti-1423	49	1	10	CARDINAL
dti-1423	50	1	8th	ORDINAL
dti-1423	50	2	institute of laboratory	ORG
dti-1423	50	3	national academy press	ORG
dti-1423	50	4	2011	DATE
dti-1423	51	1	5	CARDINAL
dti-1423	51	2	10  mg/kg	QUANTITY
dti-1423	52	1	1	CARDINAL
dti-1423	52	2	2	CARDINAL
dti-1423	54	1	areas,45,46	DATE
dti-1423	54	2	1	CARDINAL
dti-1423	56	1	3	CARDINAL
dti-1423	56	2	hmt mrna	ORG
dti-1423	57	1	brain.61–65	GPE
dti-1423	58	1	two	CARDINAL
dti-1423	58	2	1	CARDINAL
dti-1423	58	3	2	CARDINAL
dti-1423	59	1	3drug	CARDINAL
dti-1423	59	2	1	CARDINAL
dti-1423	59	3	ito et al	PERSON
dti-1423	60	1	1	CARDINAL
dti-1423	61	1	antagonists.67 hmt	PERSON
dti-1423	64	1	purposes.72–74	ORG
dti-1423	64	2	91488	DATE
dti-1423	64	3	hmt	ORG
dti-1423	64	4	malmberg-aiello et al,75	PERSON
dti-1423	64	5	91488	DATE
dti-1423	64	6	1	CARDINAL
dti-1423	65	1	hmt	ORG
dti-1423	67	1	9148874	PRODUCT
dti-1423	67	2	metoprine	ORG
dti-1423	67	3	197u	CARDINAL
dti-1423	68	1	metoprine	ORG
dti-1423	68	2	metoprine	ORG
dti-1423	68	3	al81	ORG
dti-1423	68	4	metoprine	ORG
dti-1423	69	1	metoprine	ORG
dti-1423	70	1	metoprine	ORG
dti-1423	70	2	1	CARDINAL
dti-1423	71	1	hmt	ORG
dti-1423	71	2	sah	ORG
dti-1423	71	3	sam	PERSON
dti-1423	72	1	http://www.la-press.com/drug-target-insights-journal-j23	CARDINAL
dti-1423	72	2	kitanaka et	PERSON
dti-1423	72	3	al 4	ORG
dti-1423	72	4	metoprine	ORG
dti-1423	72	5	1).65	CARDINAL
dti-1423	73	1	1	CARDINAL
dti-1423	73	2	2	CARDINAL
dti-1423	74	1	al83	PERSON
dti-1423	75	1	0.001	CARDINAL
dti-1423	75	2	metoprine	ORG
dti-1423	75	3	s. okumura	PERSON
dti-1423	75	4	t. sakamoto	PERSON
dti-1423	76	1	metoprine	ORG
dti-1423	76	2	anxiogenic79	PERSON
dti-1423	76	3	1	CARDINAL
dti-1423	77	1	10	CARDINAL
dti-1423	78	1	metoprine	ORG
dti-1423	78	2	1	CARDINAL
dti-1423	79	1	hmt	ORG
dti-1423	79	2	77	CARDINAL
dti-1423	79	3	78	CARDINAL
dti-1423	79	4	79	CARDINAL
dti-1423	79	5	metoprine	ORG
dti-1423	79	6	80	CARDINAL
dti-1423	79	7	75	CARDINAL
dti-1423	79	8	75	CARDINAL
dti-1423	79	9	metoprine	ORG
dti-1423	79	10	89	CARDINAL
dti-1423	79	11	89	CARDINAL
dti-1423	79	12	65	CARDINAL
dti-1423	79	13	90	CARDINAL
dti-1423	79	14	audiogenic	ORG
dti-1423	79	15	93	CARDINAL
dti-1423	79	16	70	CARDINAL
dti-1423	79	17	94	CARDINAL
dti-1423	79	18	71	CARDINAL
dti-1423	79	19	81	CARDINAL
dti-1423	79	20	65	CARDINAL
dti-1423	79	21	65	CARDINAL
dti-1423	79	22	301u	PERSON
dti-1423	80	1	5drug	CARDINAL
dti-1423	82	1	modafinil	PERSON
dti-1423	83	1	hmt	ORG
dti-1423	84	1	dr.	PERSON
dti-1423	84	2	tomohiro	PERSON
dti-1423	84	3	japan	GPE
dti-1423	85	1	metoprine	ORG
dti-1423	85	2	glaxosmithkline	PERSON
dti-1423	85	3	stevenage	GPE
dti-1423	85	4	uk	GPE
dti-1423	87	1	fsh	ORG
dti-1423	87	2	mt	GPE
dti-1423	87	3	nk	ORG
dti-1423	87	4	mt	GPE
dti-1423	87	5	first	ORDINAL
dti-1423	87	6	mt	GPE
dti-1423	88	1	mt	GPE
dti-1423	89	1	mt	GPE
dti-1423	89	2	mt	GPE
dti-1423	91	1	1	CARDINAL
dti-1423	91	2	sanchez-ramos j. neurologic complications	PERSON
dti-1423	93	1	2015;120:131–160. 2	CARDINAL
dti-1423	93	2	sato m.	PERSON
dti-1423	94	1	ann n y acad sci	PERSON
dti-1423	94	2	2004;1025:279–287	CARDINAL
dti-1423	95	1	3	CARDINAL
dti-1423	95	2	greberman sb	PERSON
dti-1423	95	3	wada k.	PERSON
dti-1423	96	1	the united states	GPE
dti-1423	96	2	japan	GPE
dti-1423	97	1	1994;109(6):731–737	CARDINAL
dti-1423	98	1	4	CARDINAL
dti-1423	98	2	national institute on drug	ORG
dti-1423	99	1	2014	DATE
dti-1423	101	1	september 16, 2015	DATE
dti-1423	102	1	5	CARDINAL
dti-1423	102	2	sato m.	PERSON
dti-1423	103	1	ann n y acad sci	PERSON
dti-1423	103	2	1992;654:160–170	CARDINAL
dti-1423	104	1	6	CARDINAL
dti-1423	104	2	cruickshank cc	ORG
dti-1423	104	3	dyer kr	PERSON
dti-1423	107	1	2009;104(7):1085–1099	CARDINAL
dti-1423	107	2	7	CARDINAL
dti-1423	107	3	brackins t	PERSON
dti-1423	107	4	nc	GPE
dti-1423	107	5	kissack jc.	PERSON
dti-1423	109	1	j pharm pract	ORG
dti-1423	110	1	2011;24(6):541–550	CARDINAL
dti-1423	111	1	murray jb.	PERSON
dti-1423	113	1	j psychol	PERSON
dti-1423	114	1	1998;132(2):227–237	CARDINAL
dti-1423	114	2	9	CARDINAL
dti-1423	114	3	aubin hj	PERSON
dti-1423	114	4	benyamina	PERSON
dti-1423	114	5	reynaud m	ORG
dti-1423	116	1	j clin pharmacol	PERSON
dti-1423	117	1	2010;69(6):578–592	CARDINAL
dti-1423	117	2	10	CARDINAL
dti-1423	118	1	cretzmeyer m	PERSON
dti-1423	118	2	huber dl	PERSON
dti-1423	118	3	ri	GPE
dti-1423	118	4	hall ja	PERSON
dti-1423	121	1	2003;24(3):267–277	CARDINAL
dti-1423	122	1	11	CARDINAL
dti-1423	123	1	seiden ls	GPE
dti-1423	123	2	ricaurte ga	PERSON
dti-1423	123	3	amphetamine	PERSON
dti-1423	124	1	annu rev pharmacol toxicol	ORG
dti-1423	125	1	1993;33:639–677	CARDINAL
dti-1423	126	1	12	CARDINAL
dti-1423	127	1	sulzer	ORG
dti-1423	127	2	d.	NORP
dti-1423	129	1	2011;69(4):628–649	CARDINAL
dti-1423	129	2	13	CARDINAL
dti-1423	130	1	goodwin	PERSON
dti-1423	130	2	larson ga	PERSON
dti-1423	130	3	amphetamine	PERSON
dti-1423	132	1	2009	DATE
dti-1423	132	2	284(5):2978–2989	CARDINAL
dti-1423	133	1	14	DATE
dti-1423	134	1	eshleman aj	PERSON
dti-1423	134	2	henningsen	PERSON
dti-1423	134	3	neve ka	PERSON
dti-1423	134	4	janowsky a.	PERSON
dti-1423	136	1	1994;45(2):312–316	CARDINAL
dti-1423	136	2	15	CARDINAL
dti-1423	137	1	sullivan eb	PERSON
dti-1423	137	2	glick	PERSON
dti-1423	139	1	2003;165(4):359–369	CARDINAL
dti-1423	139	2	16	CARDINAL
dti-1423	140	1	nishikawa t	PERSON
dti-1423	140	2	toru m.	PERSON
dti-1423	141	1	eur	CARDINAL
dti-1423	142	1	1983;88(2–3):195–203	CARDINAL
dti-1423	143	1	17	CARDINAL
dti-1423	143	2	grant km	PERSON
dti-1423	144	1	j neuroimmune pharmacol	PERSON
dti-1423	145	1	18	CARDINAL
dti-1423	145	2	rukngan w	GPE
dti-1423	145	3	chawanakrasaesin k	PERSON
dti-1423	148	1	2014;231(16):3099–3108	CARDINAL
dti-1423	150	1	gao k	PERSON
dti-1423	150	2	kemp de	PERSON
dti-1423	150	3	xia g	PERSON
dti-1423	150	4	calabrese jr.	PERSON
dti-1423	151	1	j clin psychopharmacol	PERSON
dti-1423	152	1	2008;28(2):203–209	CARDINAL
dti-1423	153	1	20	CARDINAL
dti-1423	154	1	haddad pm	PERSON
dti-1423	154	2	das a	GPE
dti-1423	154	3	keyhani s. antipsychotic drugs	PERSON
dti-1423	154	4	first	ORDINAL
dti-1423	155	1	2012;26(5	CARDINAL
dti-1423	156	1	21	CARDINAL
dti-1423	157	1	grant je, odlaug bl	PERSON
dti-1423	157	2	kim sw	PERSON
dti-1423	162	1	whitfield tw jr	PERSON
dti-1423	162	2	schlosburg je	PERSON
dti-1423	163	1	j neurosci	PERSON
dti-1423	165	1	23	CARDINAL
dti-1423	166	1	thorn da	PERSON
dti-1423	166	2	li jx	PERSON
dti-1423	168	1	eur	CARDINAL
dti-1423	169	1	2012;680(1–3):69–72	CARDINAL
dti-1423	169	2	24	CARDINAL
dti-1423	170	1	nguyen l	PERSON
dti-1423	170	2	kaushal n	PERSON
dti-1423	170	3	robson mj	PERSON
dti-1423	170	4	matsumoto	PERSON
dti-1423	172	1	eur	CARDINAL
dti-1423	173	1	2014;743:42–47	CARDINAL
dti-1423	173	2	25	CARDINAL
dti-1423	174	1	segal ds	PERSON
dti-1423	174	2	kuczenski r.	PERSON
dti-1423	176	1	1997;282(2):561–573. 26	CARDINAL
dti-1423	177	1	berridge cw	PERSON
dti-1423	179	1	2006;31(11):2332–2340	CARDINAL
dti-1423	180	1	27	CARDINAL
dti-1423	181	1	kitanaka n	PERSON
dti-1423	181	2	takemura m.	PERSON
dti-1423	182	1	eur	CARDINAL
dti-1423	184	1	28	CARDINAL
dti-1423	185	1	kitanaka n	PERSON
dti-1423	185	2	watabe k	PERSON
dti-1423	186	1	neurochem	PERSON
dti-1423	187	1	2006;31(6):805–813	CARDINAL
dti-1423	188	1	itzhak y	PERSON
dti-1423	188	2	martin	PERSON
dti-1423	189	1	gabapentin	ORG
dti-1423	191	1	2000;151(2–3):226–233. 30	DATE
dti-1423	192	1	niwa m	ORG
dti-1423	192	2	nitta	ORG
dti-1423	194	1	j neurosci	PERSON
dti-1423	195	1	mori t	PERSON
dti-1423	195	2	kita t	PERSON
dti-1423	196	1	eur	CARDINAL
dti-1423	197	1	2006;532(1–2):81–87	CARDINAL
dti-1423	198	1	32	CARDINAL
dti-1423	199	1	kitanaka n	PERSON
dti-1423	201	1	behav pharmacol	ORG
dti-1423	201	2	2014	DATE
dti-1423	202	1	25(2):158–165	CARDINAL
dti-1423	203	1	33	CARDINAL
dti-1423	204	1	kitanaka j	PERSON
dti-1423	205	1	4	CARDINAL
dti-1423	207	1	2012;1439:15–26	CARDINAL
dti-1423	208	1	34	CARDINAL
dti-1423	209	1	horner ka	PERSON
dti-1423	209	2	gilbert	PERSON
dti-1423	210	1	biochem behav	PERSON
dti-1423	211	1	2010;95(4):410–421	CARDINAL
dti-1423	211	2	35	CARDINAL
dti-1423	211	3	morita y	PERSON
dti-1423	211	4	m. lobeline	PERSON
dti-1423	213	1	2006	DATE
dti-1423	213	2	31(11):1359–1369	CARDINAL
dti-1423	214	1	36	CARDINAL
dti-1423	215	1	joshi vv	PERSON
dti-1423	215	2	balsara jj	PERSON
dti-1423	215	3	jadhav jh	PERSON
dti-1423	216	1	eur	CARDINAL
dti-1423	217	1	1981;69(4):499–502	CARDINAL
dti-1423	218	1	37	CARDINAL
dti-1423	218	2	mori t	PERSON
dti-1423	218	3	kita t	PERSON
dti-1423	219	1	j pharmacol sci	PERSON
dti-1423	219	2	2004;96(4):459–464	CARDINAL
dti-1423	220	1	6	CARDINAL
dti-1423	220	2	38	CARDINAL
dti-1423	221	1	morita y	PERSON
dti-1423	221	2	takemura m.	PERSON
dti-1423	222	1	biochem behav	PERSON
dti-1423	223	1	2007;87(1):48–55	CARDINAL
dti-1423	223	2	39	DATE
dti-1423	224	1	kitanaka j	PERSON
dti-1423	224	2	sigma1	GPE
dti-1423	227	1	2009;203(4):781–792	CARDINAL
dti-1423	227	2	40	DATE
dti-1423	227	3	gianutsos g	PERSON
dti-1423	227	4	morrow	DATE
dti-1423	227	5	sweeney mj	PERSON
dti-1423	229	1	biochem behav	PERSON
dti-1423	230	1	1982;17(5):951–954	CARDINAL
dti-1423	230	2	41	CARDINAL
dti-1423	231	1	kitanaka n	PERSON
dti-1423	231	2	takemura m. inhibition	PERSON
dti-1423	231	3	5	CARDINAL
dti-1423	233	1	2005;130(2):295–308	CARDINAL
dti-1423	234	1	42	DATE
dti-1423	235	1	amin k.	PERSON
dti-1423	237	1	respir med.	PERSON
dti-1423	238	1	2012;106(1	CARDINAL
dti-1423	239	1	43	CARDINAL
dti-1423	240	1	cataldi m	PERSON
dti-1423	240	2	borriello	GPE
dti-1423	240	3	granata f	PERSON
dti-1423	240	4	marone g.	PERSON
dti-1423	241	1	chem immunol allergy	PERSON
dti-1423	242	1	2014;100:214–226	CARDINAL
dti-1423	244	1	huang jf	PERSON
dti-1423	244	2	thurmond	PERSON
dti-1423	246	1	curr	PERSON
dti-1423	246	2	2008;8(1):21–27	CARDINAL
dti-1423	247	1	45	CARDINAL
dti-1423	248	1	watanabe t	PERSON
dti-1423	248	2	taguchi y	PERSON
dti-1423	249	1	neurosci lett.	PERSON
dti-1423	251	1	46	CARDINAL
dti-1423	252	1	panula	GPE
dti-1423	253	1	yang hy	PERSON
dti-1423	253	2	costa e. histamine-containing	PERSON
dti-1423	254	1	sci u s a. 1984;81(8):2572–2576	ORG
dti-1423	255	1	47	CARDINAL
dti-1423	256	1	prell gd	PERSON
dti-1423	256	2	green jp	PERSON
dti-1423	257	1	annu rev neurosci	ORG
dti-1423	258	1	1986;9	CARDINAL
dti-1423	259	1	209–254	CARDINAL
dti-1423	260	1	48	CARDINAL
dti-1423	260	2	stevens dr	PERSON
dti-1423	260	3	haas hl	PERSON
dti-1423	263	1	2001;63(6):637–672	CARDINAL
dti-1423	263	2	49	DATE
dti-1423	264	1	haas hl	PERSON
dti-1423	265	1	physiol rev	PERSON
dti-1423	265	2	2008;88(3):1183–1241.	CARDINAL
dti-1423	267	1	roberts f	PERSON
dti-1423	269	1	721–739	CARDINAL
dti-1423	270	1	51	CARDINAL
dti-1423	271	1	jones	PERSON
dti-1423	273	1	biosci	GPE
dti-1423	274	1	2003;8	CARDINAL
dti-1423	274	2	s451	DATE
dti-1423	275	1	52	CARDINAL
dti-1423	276	1	nuutinen	ORG
dti-1423	276	2	panula p.	PERSON
dti-1423	279	1	53	CARDINAL
dti-1423	280	1	fukagawa k	PERSON
dti-1423	280	2	sakata t	GPE
dti-1423	280	3	shiraishi t	GPE
dti-1423	281	1	j physiol	PERSON
dti-1423	282	1	2	CARDINAL
dti-1423	283	1	54	DATE
dti-1423	284	1	wada h	ORG
dti-1423	284	2	watanabe t.	PERSON
dti-1423	286	1	1991;14(9	CARDINAL
dti-1423	286	2	415–418	CARDINAL
dti-1423	287	1	55	CARDINAL
dti-1423	288	1	ogasawara m	PERSON
dti-1423	288	2	yamauchi k	PERSON
dti-1423	290	1	j pharmacol sci	PERSON
dti-1423	291	1	2006;101(1):24–30	CARDINAL
dti-1423	292	1	56	CARDINAL
dti-1423	293	1	yoshikawa t	ORG
dti-1423	293	2	iida t	PERSON
dti-1423	296	1	2013;61(6):905–916	CARDINAL
dti-1423	297	1	57	CARDINAL
dti-1423	298	1	mizuguchi h	ORG
dti-1423	298	2	fukui h	GPE
dti-1423	298	3	yamatodani a.	PERSON
dti-1423	299	1	sci.	ORG
dti-1423	301	1	58	DATE
dti-1423	302	1	kitanaka n	PERSON
dti-1423	302	2	oue t	PERSON
dti-1423	302	3	tanaka t	PERSON
dti-1423	303	1	jpn j pharmacol	PERSON
dti-1423	304	1	2002;88(1):85–92	CARDINAL
dti-1423	304	2	59	CARDINAL
dti-1423	305	1	kitanaka j	PERSON
dti-1423	305	2	tsujimura	GPE
dti-1423	306	1	eur	CARDINAL
dti-1423	307	1	2002	DATE
dti-1423	308	1	60	CARDINAL
dti-1423	309	1	watanabe t	PERSON
dti-1423	309	2	maeyama k	PERSON
dti-1423	309	3	wada h.	ORG
dti-1423	309	4	n tau-methylhistamine	PERSON
dti-1423	311	1	1984;96(6	CARDINAL
dti-1423	311	2	1931–1937	CARDINAL
dti-1423	312	1	61	CARDINAL
dti-1423	313	1	ito	PERSON
dti-1423	313	2	watanabe t.	PERSON
dti-1423	315	1	1996;734(1–2):98–102	CARDINAL
dti-1423	316	1	62	CARDINAL
dti-1423	317	1	ito	PERSON
dti-1423	317	2	watanabe t	PERSON
dti-1423	317	3	sato m.	PERSON
dti-1423	318	1	clin neurosci	PERSON
dti-1423	319	1	1997;51(2):79–81.	CARDINAL
dti-1423	321	1	john j	PERSON
dti-1423	321	2	kodama t	PERSON
dti-1423	321	3	siegel jm	PERSON
dti-1423	322	1	j physiol	PERSON
dti-1423	322	2	comp	NORP
dti-1423	323	1	2014;307(6):r704	CARDINAL
dti-1423	325	1	subramanian n	PERSON
dti-1423	325	2	mitznegg p	PERSON
dti-1423	330	1	1980;20(1):42–45.	DATE
dti-1423	332	1	kitanaka j	PERSON
dti-1423	332	2	takemura m. blockade	PERSON
dti-1423	334	1	2007;147(3):765–777	CARDINAL
dti-1423	334	2	66	CARDINAL
dti-1423	335	1	muley mp	PERSON
dti-1423	335	2	balsara jj	PERSON
dti-1423	336	1	indian	NORP
dti-1423	336	2	j physiol pharmacol	PERSON
dti-1423	337	1	1979;23(4):291–296	CARDINAL
dti-1423	338	1	67	CARDINAL
dti-1423	339	1	ito	PERSON
dti-1423	339	2	watanabe t	GPE
dti-1423	341	1	1997;130(4):362–367	CARDINAL
dti-1423	342	1	68	CARDINAL
dti-1423	343	1	zawilska	PERSON
dti-1423	343	2	nowak jz	PERSON
dti-1423	344	1	j pharmacol pharm	PERSON
dti-1423	345	1	1985;37(6):821–830	CARDINAL
dti-1423	349	1	1991;56(3):769–774	CARDINAL
dti-1423	350	1	70	CARDINAL
dti-1423	351	1	yokoyama h	PERSON
dti-1423	351	2	maeyama k	PERSON
dti-1423	352	1	naunyn	GPE
dti-1423	354	1	71	CARDINAL
dti-1423	355	1	yawata	PERSON
dti-1423	356	1	tanaka k	PERSON
dti-1423	356	2	nakagawa y	PERSON
dti-1423	356	3	watanabe y	PERSON
dti-1423	356	4	nakano k.	PERSON
dti-1423	358	1	2004;132(1):13–17	CARDINAL
dti-1423	359	1	72	DATE
dti-1423	360	1	duch ds	PERSON
dti-1423	360	2	edelstein mp	PERSON
dti-1423	360	3	nichol	PERSON
dti-1423	362	1	antitrypanosomal	PERSON
dti-1423	363	1	biochem pharmacol	ORG
dti-1423	364	1	1984;33(9):1547–1553	CARDINAL
dti-1423	365	1	73	CARDINAL
dti-1423	366	1	duch ds	PERSON
dti-1423	366	2	bowers sw	PERSON
dti-1423	366	3	nichol	PERSON
dti-1423	370	1	74	DATE
dti-1423	371	1	beaven ma	PERSON
dti-1423	371	2	91488	DATE
dti-1423	373	1	1979;9(5–6):455–460	CARDINAL
dti-1423	374	1	75	DATE
dti-1423	375	1	malmberg-aiello	PERSON
dti-1423	375	2	lamberti c	PERSON
dti-1423	375	3	hanninen j	PERSON
dti-1423	375	4	bartolini a.	PERSON
dti-1423	375	5	two	CARDINAL
dti-1423	375	6	91488	DATE
dti-1423	375	7	301 u	PERCENT
dti-1423	376	1	naunyn	GPE
dti-1423	377	1	1997;355(3):354–360	CARDINAL
dti-1423	378	1	76	DATE
dti-1423	379	1	nichol	PERSON
dti-1423	379	2	cavallito jc	PERSON
dti-1423	379	3	woolley jl, sigel cw	ORG
dti-1423	382	1	lecklin	PERSON
dti-1423	382	2	macdonald e. metoprine	PERSON
dti-1423	383	1	clin pharmacol	ORG
dti-1423	384	1	1995;17(1):47–52	CARDINAL
dti-1423	386	1	lecklin	PERSON
dti-1423	386	2	eriksson l	ORG
dti-1423	386	3	tarhanen j	PERSON
dti-1423	386	4	wistar rats	ORG
dti-1423	387	1	physiol scand	PERSON
dti-1423	388	1	1999;165(3):325–333. 79	DATE
dti-1423	389	1	malmberg-aiello	PERSON
dti-1423	389	2	w. mouse	PERSON
dti-1423	390	1	biochem behav	PERSON
dti-1423	391	1	2002;71(1–2):313–318	CARDINAL
dti-1423	392	1	80	DATE
dti-1423	393	1	malmberg-aiello p	ORG
dti-1423	393	2	w. antiamnesic	PERSON
dti-1423	394	1	neurosci lett	PERSON
dti-1423	395	1	2000;288(1):1–4	CARDINAL
dti-1423	396	1	81	DATE
dti-1423	397	1	itoh y	PERSON
dti-1423	399	1	neurosci lett.	PERSON
dti-1423	399	2	1984	DATE
dti-1423	399	3	48(3):305–309	CARDINAL
dti-1423	400	1	82	CARDINAL
dti-1423	401	1	kitanaka j	PERSON
dti-1423	402	1	biochem behav	PERSON
dti-1423	403	1	2010;94(3):464–470	CARDINAL
dti-1423	403	2	83	DATE
dti-1423	404	1	iwabuchi k	PERSON
dti-1423	404	2	watanabe t	PERSON
dti-1423	404	3	yanai k. methamphetamine	PERSON
dti-1423	405	1	ann n y acad sci	PERSON
dti-1423	405	2	2004;1025:129–134. 84	DATE
dti-1423	406	1	munzar p	ORG
dti-1423	406	2	goldberg sr	PERSON
dti-1423	408	1	eur	CARDINAL
dti-1423	409	1	1998;363(2–3):93–101	CARDINAL
dti-1423	410	1	munzar p	ORG
dti-1423	410	2	tanda g	PERSON
dti-1423	410	3	justinova	PERSON
dti-1423	410	4	goldberg sr.	PERSON
dti-1423	413	1	2004;29(4	CARDINAL
dti-1423	414	1	705–717	CARDINAL
dti-1423	415	1	86	CARDINAL
dti-1423	416	1	kitanaka j	PERSON
dti-1423	418	1	neurochem	PERSON
dti-1423	420	1	87	DATE
dti-1423	421	1	kitanaka j	PERSON
dti-1423	421	2	japanese	NORP
dti-1423	423	1	2015;18(2):83–88	CARDINAL
dti-1423	424	1	pan jb	PERSON
dti-1423	425	1	4-(2-{2-[(2r)-2	CARDINAL
dti-1423	427	1	2005;313(1):176–190. 89	DATE
dti-1423	428	1	sakai n	PERSON
dti-1423	428	2	maeyama k	PERSON
dti-1423	428	3	yanai k	PERSON
dti-1423	428	4	watanabe t.	PERSON
dti-1423	429	1	sci	ORG
dti-1423	429	2	1992;51(6):397–405. 90	DATE
dti-1423	430	1	bazyan	NORP
dti-1423	430	2	l. metoprine	PERSON
dti-1423	430	3	wistar rats	ORG
dti-1423	432	1	2012;101(1–2):148–156	CARDINAL
dti-1423	433	1	91	CARDINAL
dti-1423	434	1	bristow lj	PERSON
dti-1423	434	2	bennett gw.	PERSON
dti-1423	438	1	7drug	ORG
dti-1423	438	2	2016:10 92	CARDINAL
dti-1423	439	1	nasello ag	ORG
dti-1423	439	2	bernardi mm	PERSON
dti-1423	440	1	sci. 1998;62(20):1875–1888	ORG
dti-1423	441	1	93	CARDINAL
dti-1423	441	2	tuomisto l	ORG
dti-1423	441	3	tacke u	PERSON
dti-1423	441	4	willman a. inhibition	PERSON
dti-1423	442	1	252–254	CARDINAL
dti-1423	443	1	94	CARDINAL
dti-1423	444	1	kakinoki h, ishizawa k	ORG
dti-1423	444	2	fujii y	PERSON
dti-1423	444	3	kamei c.	PERSON
dti-1423	447	1	1998;46(5):461–465	CARDINAL
dti-1423	448	1	95	CARDINAL
dti-1423	449	1	castellan baldan l	PERSON
dti-1423	449	2	williams ka	PERSON
dti-1423	449	3	gallezot jd	PERSON
dti-1423	451	1	2014;81(1):77–90	CARDINAL
dti-1423	452	1	96	CARDINAL
dti-1423	453	1	arrang jm	PERSON
dti-1423	453	2	schwartz jc.	PERSON
dti-1423	455	1	97	CARDINAL
dti-1423	456	1	ishizuka t	PERSON
dti-1423	456	2	sakamoto y	PERSON
dti-1423	456	3	sakurai t	PERSON
dti-1423	456	4	yamatodani a. modafinil	PERSON
dti-1423	457	1	neurosci lett	PERSON
dti-1423	458	1	2003;339(2):143–146	CARDINAL